NIH to evaluate remdesivir treatment for COVID during pregnancy

WASHINGTON (NEWS10) — The National Institutes of Health (NIH) is funding a study into the effects of prescription remdesivir on those who are both pregnant and COVID-positive. Called “IMPAACT 2032,” the study, conducted at 17 sites in the U.S., will examine how pregnant people metabolize and digest the drug, and whether it poses side effects. […]

Favipiravir, camostat, and ciclesonide combination therapy in

Is it possible to reduce the rate of vertical transmission and

Relationship of COVID-19 with pregnancy - ScienceDirect

Clinical outcomes of hospitalized COVID-19 patients treated with

Real-life comparison of mortality in patients with SARS-CoV-2

2020 Archive - UM School of Medicine Researchers Test Remdesivir

13 Things To Know About Paxlovid, the Latest COVID-19 Pill > News

Diagnosis and management of covid-19 in pregnancy

Targeting SARS-CoV-2: An overview of COVID-19 treatments

SARS-CoV-2 infection in pregnancy: A systematic review and meta

COVID-19 in people with rheumatic diseases: risks, outcomes

Remdesivir for the treatment of hospitalized patients with severe

Infectious Disease Reports, Free Full-Text

Remdesivir in pregnant women with moderate to severe coronavirus

Comparative therapeutic efficacy of remdesivir and combination